Summary
Rhonda Patrick interviews Dr. Peter Attia, physician and author of Outlive, in an extensive conversation spanning cardiovascular disease, cancer prevention, exercise science, and hormone replacement therapy. Attia explains how ApoB is the strongest predictor of cardiovascular disease risk, discusses what dietary factors raise ApoB, and breaks down the evidence on statins including their benefits, side effects, and potential mitochondrial toxicity.
The episode covers Attia's 80/20 training protocol combining Zone 2 cardio with VO2 max work, insights from his VO2 max testing data, and how muscle serves as a glucose sink for metabolic health. They explore the relationship between obesity and cancer risk, practical cancer screening strategies, and a deep dive into hormone replacement therapy for menopause — covering its effects on dementia, cancer, heart disease risk, and sexual function. The conversation closes with blood pressure management and Attia's personal longevity optimization routines.
Key Points
- ApoB is the strongest predictor of cardiovascular disease and should be a primary screening target
- Statins are effective for CVD risk reduction but may have mitochondrial side effects; ubiquinol can help with statin-induced muscle soreness
- Zone 2 training combined with VO2 max work in an 80/20 ratio optimizes cardiovascular fitness and longevity
- Muscle mass acts as a glucose sink, making strength training critical for metabolic health
- Obesity significantly increases cancer risk through multiple mechanisms
- Hormone replacement therapy during menopause can reduce dementia and heart disease risk when started at the right time
- Vitamin D, testosterone management, and blood pressure optimization are key longevity levers
Key Moments
Peter Attia on ApoB, lipid management, and why diet alone rarely fixes cholesterol
Peter Attia explains why ApoB is a superior cardiovascular risk predictor and covers the limits of using diet alone to manage lipid levels.
"I believe that using nutrition to solve the lipid problem is not a good solution. Use nutrition to address energy balance, protein needs, anabolic structure, energy."
Why restricting fat to lower cholesterol often backfires metabolically
Extreme dietary fat restriction can cause insulin resistance and poor carb quality. Attia recommends solving lipids with pharmacology and using nutrition for energy and protein.
"A lot of times when I see people on these excessively restrictive fat lowering diets, they actually become insulin resistant. A lot of them because they're really over consuming a lot of poor quality carbs."
HRT timing for Alzheimer's risk: early initiation may protect APOE4 carriers
Late HRT initiation may increase Alzheimer's risk, while early initiation at menopause appears beneficial specifically for women carrying the APOE4 allele.
"Late initiation of HRT may be counterproductive for AD risk. Early initiation appears to potentially only be beneficial in E4 women, but not E3 women."
Danish DOPS study: 11 years of early HRT reduced cardiovascular mortality
The DOPS study showed that women starting HRT between ages 45-58 had reduced cardiovascular disease risk and mortality over 16 years of follow-up.
"This is to me the biggest unknown question, and we don't know the answer. And what I find very frustrating is we're not going to know the answer because nobody's going to do the study."
Testosterone replacement: early cardiac risk spike, then benefits at 2-3 years
A large TRT study showed slightly increased cardiac events at year one that vanished by year two, likely from blood pressure effects in the highest-risk men.
"We're very aggressive. If you look at the sprint trial, I think it's very clear that 120 over 80 or better is the place to be."
